Analyst Price Target is $5.00
▲ +471.82% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Salarius Pharmaceuticals in the last 3 months. The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. The average price target represents a 471.82% upside from the last price of $0.87.
Current Consensus is
The current consensus among 1 contributing investment analysts is to buy stock in Salarius Pharmaceuticals.